Literature DB >> 26759244

Cdx2 Expression and Intestinal Metaplasia Induced by H. pylori Infection of Gastric Cells Is Regulated by NOD1-Mediated Innate Immune Responses.

Naoki Asano1, Akira Imatani2, Tomohiro Watanabe3, Jun Fushiya2, Yutaka Kondo2, Xiaoyi Jin2, Nobuyuki Ara2, Kaname Uno2, Katsunori Iijima2, Tomoyuki Koike2, Warren Strober4, Tooru Shimosegawa2.   

Abstract

Chronic infection with the bacterial Helicobacter pylori is a major cause of gastric and duodenal ulcer disease, gastric mucosal atrophy, and cancer. H. pylori-induced expression of the intestinal epithelial-specific transcription factor caudal-related homeobox 2 (Cdx2) contributes to intestinal metaplasia, a precursor event to gastric cancer. Given a role for the bacterial pattern recognition molecule nucleotide-binding oligomerization domain 1 (NOD1) in the innate immune response to bacterial infection, we investigated mechanisms used by NOD1 to regulate H. pylori infection and its propensity towards the development of intestinal metaplasia. We found that Cdx2 was induced by H. pylori infection in both normal and neoplastic gastric epithelial cells in a manner that was inversely related to NOD1 signaling. Mechanistic investigations revealed that Cdx2 induction relied upon activation of NF-κB but was suppressed by NOD1-mediated activation of TRAF3, a negative regulator of NF-κB. In vivo, prolonged infection of NOD1-deficient mice with H. pylori led to increased Cdx2 expression and intestinal metaplasia. Furthermore, gastric epithelial cells from these mice exhibited increased nuclear expression of the NF-κB p65 subunit and decreased expression of TRAF3. Overall, our findings illuminated a role for NOD1 signaling in attenuating H. pylori-induced Cdx2 expression in gastric epithelial cells, suggesting a rationale to augment NOD1 signaling in H. pylori-infected patients to limit their risks of accumulating precancerous gastric lesions. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26759244      PMCID: PMC4799656          DOI: 10.1158/0008-5472.CAN-15-2272

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  Mucins as key molecules for the classification of intestinal metaplasia of the stomach.

Authors:  Elisabete Silva; Ana Teixeira; Leonor David; Fátima Carneiro; Celso A Reis; Joana Sobrinho-Simões; Jacinta Serpa; Enno Veerman; Jan Bolscher; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2001-12-15       Impact factor: 4.064

Review 2.  Pathophysiology of intestinal metaplasia of the stomach: emphasis on CDX2 regulation.

Authors:  Rita Barros; Vânia Camilo; Bruno Pereira; Jean-Noel Freund; Leonor David; Raquel Almeida
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

3.  NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway.

Authors:  Tomohiro Watanabe; Naoki Asano; Stefan Fichtner-Feigl; Peter L Gorelick; Yoshihisa Tsuji; Yuko Matsumoto; Tsutomu Chiba; Ivan J Fuss; Atsushi Kitani; Warren Strober
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

4.  Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.

Authors:  Xiaofang Huo; Hui Ying Zhang; X I Zhang; John P Lynch; Eric D Strauch; Jian-Ying Wang; Shelby D Melton; Robert M Genta; David H Wang; Stuart J Spechler; Rhonda F Souza
Journal:  Gastroenterology       Date:  2010-03-17       Impact factor: 22.682

5.  Association of Helicobacter pylori antioxidant activities with host colonization proficiency.

Authors:  Adriana A Olczak; Richard W Seyler; Jonathan W Olson; Robert J Maier
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

6.  Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice.

Authors:  Hiroyuki Mutoh; Yoji Hakamata; Kiichi Sato; Akashi Eda; Ichiro Yanaka; Sayaka Honda; Hiroyuki Osawa; Yoshinari Kaneko; Kentaro Sugano
Journal:  Biochem Biophys Res Commun       Date:  2002-06-07       Impact factor: 3.575

7.  Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination.

Authors:  Acacia Lamb; Xiao-Dong Yang; Ying-Hung N Tsang; Jiang-Dong Li; Hideaki Higashi; Masanori Hatakeyama; Richard M Peek; Steven R Blanke; Lin-Feng Chen
Journal:  EMBO Rep       Date:  2009-10-09       Impact factor: 8.807

8.  PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.

Authors:  Sunghoon Kim; Claire Domon-Dell; Qingding Wang; Dai H Chung; Antonio Di Cristofano; Pier Paolo Pandolfi; Jean-Noel Freund; B Mark Evers
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

9.  The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides.

Authors:  Alexandra Grubman; Maria Kaparakis; Jérôme Viala; Cody Allison; Luminita Badea; Abdulgader Karrar; Ivo G Boneca; Lionel Le Bourhis; Shane Reeve; Ian A Smith; Elizabeth L Hartland; Dana J Philpott; Richard L Ferrero
Journal:  Cell Microbiol       Date:  2009-12-21       Impact factor: 3.715

10.  NOD1 and NOD2 Genetic Variants in Association with Risk of Gastric Cancer and Its Precursors in a Chinese Population.

Authors:  Zhe-Xuan Li; Yu-Mei Wang; Fu-Bing Tang; Lian Zhang; Yang Zhang; Jun-Ling Ma; Tong Zhou; Wei-Cheng You; Kai-Feng Pan
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

View more
  20 in total

1.  Expression and significance of CDX2, FXR, and TGR5 in esophageal cancer.

Authors:  Hongying Zhang; Xiaodong Qu; Na Wang; Lifeng Zhang; Ting Yuan; Miao Shi; Nina Sun; Donghong Yuan; Hanbing Ning; Mengyun Zhao; Yongxi Wang; Zhen Ni; Chuan Han; Yongquan Shi
Journal:  Int J Clin Exp Pathol       Date:  2022-09-15

2.  TLR9 activation suppresses inflammation in response to Helicobacter pylori infection.

Authors:  Matthew G Varga; M Blanca Piazuelo; Judith Romero-Gallo; Alberto G Delgado; Giovanni Suarez; Morgan E Whitaker; Uma S Krishna; Rachna V Patel; Eric P Skaar; Keith T Wilson; Holly M S Algood; Richard M Peek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-10-06       Impact factor: 4.052

3.  Methylation of promoter region of CDX2 gene in colorectal cancer.

Authors:  Yunshuai Wang; Zhaohui Li; Wenxian Li; Shuaifeng Liu; Baowei Han
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

Review 4.  NF-κB Signaling in Gastric Cancer.

Authors:  Olga Sokolova; Michael Naumann
Journal:  Toxins (Basel)       Date:  2017-03-28       Impact factor: 4.546

5.  hTERT promotes gastric intestinal metaplasia by upregulating CDX2 via NF-κB signaling pathway.

Authors:  Bai-Jun Chen; Shuo Zeng; Rui Xie; Chang-Jiang Hu; Su-Ming Wang; Yu-Yun Wu; Yu-Feng Xiao; Shi-Ming Yang
Journal:  Oncotarget       Date:  2017-04-18

6.  HpSlyD inducing CDX2 and VIL1 expression mediated through TCTP protein may contribute to intestinal metaplasia in the stomach.

Authors:  Qiuping Li; Yanmei Zhu; Jun Liu; Xiuwen Yu; Moye Chen; Nannan Dong; Yuehua Gong; Yuan Yuan
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

7.  Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer.

Authors:  Qirong Geng; Jianjun Liu; Zhaohui Gong; Shangxiang Chen; Shuai Chen; Xiaoxing Li; Yue Lu; Xiaofeng Zhu; Hui-Kuan Lin; Dazhi Xu
Journal:  Mol Cancer       Date:  2017-04-26       Impact factor: 27.401

8.  Lauren classification and individualized chemotherapy in gastric cancer.

Authors:  Junli Ma; Hong Shen; Linda Kapesa; Shan Zeng
Journal:  Oncol Lett       Date:  2016-03-16       Impact factor: 2.967

Review 9.  Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders.

Authors:  Tomohiro Watanabe; Naoki Asano; Masatoshi Kudo; Warren Strober
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

Review 10.  Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: A review.

Authors:  Kosuke Minaga; Tomohiro Watanabe; Ken Kamata; Naoki Asano; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2018-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.